Skip to main content
Premium Trial:

Request an Annual Quote

Kerry Flom, Waun Ki Hong, Jay Tischfield, David Alberts, Michael Hogan

Premium

Kerry Flom has joined Cepheid as vice president of clinical affairs, the company announced on June 30. Most recently, he directed the clinical and regulatory submissions group at Abbott Molecular Diagnostics. Prior to that, he directed the clinical affairs departments at Vysis. Flom holds a PhD in biochemistry from the University of Illinois at Urbana-Champaign.


Waun Ki Hong of the MD Anderson Cancer Center at the University of Texas, Jay Tischfield of the Rutgers University Department of Genetics, and David Alberts of the Arizona Cancer Center at the University of Arizona join GenVault’s new scientific advisory board. Michael Hogan, chief scientific officer, will serve as director of the board, the company said this week.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.